Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

Similar Items

• CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
  od: Miri, Seyed Mohammad, i dr.
  Izdano: (2020)
• Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
  od: Seyed Mohammad Miri, i dr.
  Izdano: (2020-10-01)
• CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
  od: Salas-Mckee, January, i dr.
  Izdano: (2019)
• Gene editing (CRISPR-Cas) technology and fisheries sector
  od: A.D. Diwan, i dr.
  Izdano: (2017-07-01)
• CRISPR-Cas systems: ushering in the new genome editing era
  od: Perez Rojo, Fernando, i dr.
  Izdano: (2018)